| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 5,571,148 | | Cost of Revenue | 2,856,706 | | | Gross Profit | 2,714,441 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 1,403,056 | | Non Recurring |
-
| | Others | 655,427 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 655,959 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (192,313) | | Earnings Before Interest And Taxes | 463,645 | | Interest Expense | 108,939 | | Income Before Tax | 354,706 | | Income Tax Expense | 117,690 | | Minority Interest | (6,997) | | | | Net Income From Continuing Ops | 243,985 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 243,985 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $243,985 |
|
1.23% Nasdaq 
Income Statement
